Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of GeneDx Holdings Corp. (NASDAQ:WGS) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.
GeneDx reported quarterly losses of 33 cents per share which beat the analyst consensus estimate of losses of 67 cents. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million, according to data from Benzinga Pro.
GeneDx raised its full-year 2024 revenue guidance to between $235 million and $245 million, up from $220 million to $230 million, and expanded its full-year 2024 adjusted gross margin profile to at least 60% from at least 50%.
GeneDx Holdings shares climbed 37.4% to $15.11 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) gained 72.1% to $2.34 in pre-market trading after falling over 9% on Monday.
- Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) gained 31% to $0.0851 in pre-market trading.
- Marin Software Incorporated (NASDAQ:MRIN) rose 24.1% to $3.24 in today's pre-market trading after the company announced the launch of its AI-powered Anomaly Detector.
- Blend Labs, Inc. (NYSE:BLND) shares gained 20% to $2.70 in pre-market trading after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.
- Addex Therapeutics Ltd (NASDAQ:ADXN) jumped 20% to $9.05 in pre-market trading. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.
- Movano Inc. (NASDAQ:MOVE) shares gained 18.6% to $0.5461 in pre-market trading after declining over 5% on Monday.
- Sensata Technologies Holding plc (NYSE:ST) shares climbed 15.8% to $41.43 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.
- Warrantee Inc. (NASDAQ:WRNT) shares rose 14.7% to $0.3199 in pre-market trading. Warrantee shares fell over 6% on Monday after the company announced a receipt of a Nasdaq delising determination and a plan to appeal.
- Logitech International S.A. (NASDAQ:LOGI) shares gained 7.7% to $85.59 in pre-market trading following better-than-expected fourth-quarter results.
- Lichen China Limited (NASDAQ:LICN) fell 28.1% to $1.46 in pre-market trading after surging 48% on Monday.
- Medifast, Inc. (NYSE:MED) shares declined 15.6% to $29.95 in pre-market trading after the company reported mixed first-quarter financial results.
- iClick Interactive Asia Group Limited (NASDAQ:ICLK) fell 15.3% to $1.00 pre-market trading after declining 5% on Monday. iClick Interactive Asia recently announced the termination of its merger agreement.
- Safe & Green Holdings Corp (NASDAQ:SGBX) fell 14.9% to $0.12 in pre-market trading after declining 4% on Monday.
- Intelligent Living Application Group Inc. (NASDAQ:ILAG) shares fell 14.2% to $0.6410 in pre-market trading after gaining 8% on Monday.
- Complete Solaria, Inc. (NASDAQ:CSLR) fell 13.7% to $0.6303 pre-market trading. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.
- BioSig Technologies Inc (NASDAQ:BSGM) shares fell 13.4% to $1.16 in pre-market trading.
- Coursera, Inc. (NYSE:COUR) shares declined 12.7% to $10.37 in pre-market trading after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.
- Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) shares declined 12.3% to $2.43 in pre-market trading.
- Chegg, Inc. (NYSE:CHGG) shares fell 12.1% to $6.30 in pre-market trading after the company posted first-quarter results and named Nathan Shultz as CEO.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.